GoodRxvsMicrosoft

GDRX and MSFT stock compared: price, dividend, valuation and results, from SEC filings.

GDRX

GoodRx Holdings, Inc.

$3.47

Value $1.2B

-1.14%
GDRX's page

MSFT

Microsoft Corporation

$506.24

Value $3.76T

-2.27%
MSFT's page

GoodRx (GDRX) has a market value of $1.2B and Microsoft (MSFT) $3.76T. Over the last year, with dividends, GDRX moved +16.8% and MSFT +0.0%. The P/E is 76.1 for GDRX and 26.4 for MSFT. Dividend yield: GDRX none, MSFT 0.72%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GDRX$1.2B

    MSFT$3.76T

    MSFT is 3,040 times GDRX

  • Revenue, 12 months

    GDRX$785M

    MSFT$346B

    MSFT is 441 times GDRX

  • Net income, 12 months

    GDRX$16M

    MSFT$143B

    MSFT is 8,778 times GDRX

  • Operating margin

    GDRX9.5%

    MSFT47.1%

    37.6 points apart

  • ROIC

    GDRX5.3%

    MSFT28.7%

    23.4 points apart

  • P/E

    GDRX76.1

    MSFT26.4

    GDRX is 2.9 times MSFT

  • Dividend yield

    GDRX0.0%

    MSFT0.7%

    0.7 points apart

  • 5-year return

    GDRX-91.3%

    MSFT+55.4%

    146.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GDRX-91.3%

MSFT+55.4%

05010015020222023202420252026
Returns by period
PeriodGDRXWith dividendsMSFTWith dividends
1 year since November 14, 2025+16.8%Price +16.8%+0.0%Price -0.8%
3 years since November 17, 2023-33.7%-12.8% a yearPrice -33.7%+39.8%+11.8% a yearPrice +36.9%
5 years since November 16, 2021-91.3%-38.7% a yearPrice -91.3%+55.4%+9.2% a yearPrice +49.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GDRXGoodRxMSFTMicrosoft

Valuation

GDRXMSFT
Valuation
Price$3.47$506.24
Market value$1.2B$3.76T
Enterprise value (EV)$1.4B$3.80T
P/E76.126.4
P/E, 5-year median–35.2
P/B1.98.0
EV/EBIT19.023.3
Free cash flow yield15.9%1.6%

Results and growth

GDRXMSFT
Results and growth
Revenue, 12 months$785M$346B
Net income, 12 months$16M$143B
Free cash flow, 12 months$197M$60.0B
Earnings per share, 12 months$0.05$19.16
Revenue growth, year on year0.6%17.8%
Revenue growth a year, past+7.7%over 5 years+14.6%over 5 years
EPS growth a year, past–+17.4%over 5 years

Margins and returns on capital

GDRXMSFT
Margins and returns on capital
Gross margin90.8%67.7%
Operating margin9.5%47.1%
Net margin2.1%41.2%
ROIC5.3%28.7%
ROE2.6%34.3%

Balance sheet

GDRXMSFT
Balance sheet
Cash$296M$64.5B
Total debt$539M$134B
Net debt / EBITDA1.20.2
Interest cover1.8×50.6×

Dividends and buybacks

GDRXMSFT
Dividends and buybacks
Dividend yield–0.7%
Dividend per share, 12 months–$3.64
Dividend growth a year, past–+10.2%over 5 years
Buyback yield17.5%0.6%
Shareholder yield17.5%1.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GDRX or MSFT

Didn't find what you were looking for?

Ask us
Which is bigger, GoodRx or Microsoft?

By market value, Microsoft ($3.76T) is about 3,040.2 times GoodRx ($1.2B), at today's prices.

How did GDRX and MSFT stock do over the last 5 years?

Since November 16, 2021, GDRX's price moved -91.3% and MSFT's +49.1%. With dividends: GDRX -91.3% (-38.7% a year), MSFT +55.4% (+9.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, GDRX or MSFT?

The dividend yield at today's price is none for GoodRx and 0.72% for Microsoft. Over the last twelve months they paid – and $3.64 per share.

What is the P/E of GDRX and MSFT?

At today's price, the P/E is 76.1 for GDRX and 26.4 for MSFT. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, GoodRx or Microsoft?

Over the last twelve months, the net margin was 2.1% for GoodRx and 41.2% for Microsoft, and the operating margin 9.5% and 47.1%. Revenue was $785M and $346B.

Which is the better investment, GoodRx or Microsoft?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.